Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-28

Clinical Trial Update: Support of Colonization Resistance of the Gut Microbiota with the Synbiotic Food Supplement Nagasin® [NA]

View source ↗

Summary

A University of Zurich-sponsored trial is evaluating Nagasin, a synbiotic food supplement, for improving colonization resistance of the gut microbiota in C. dif…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nagasin

Snippet

Sponsor: University of Zurich | Conditions: C. Difficile Enteritis | NA | Status: ACTIVE_NOT_RECRUITING